New hope for Hard-to-Treat myeloma: first human trial launches
Disease control
Recruiting now
This early-stage study tests a new drug called ISB 2001 in people with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check the drug's safety and how well it fights the cancer. About 200 participants will receive the drug in…
Phase: PHASE1 • Sponsor: Ichnos Sciences SA • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC